Reporte zur Charge 204521A

Symptomtext

COVID AFTER RECEIVING THE JANSSEN COVID 19 VACCINE; This spontaneous report received from a patient concerned a 40 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204521A expiry: UNKNOWN) dose was not reported, administered on 10-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-JAN-2022, the patient experienced covid after receiving the Janssen Covid 19 vaccine. Laboratory data included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid after receiving the Janssen Covid 19 vaccine was not reported. This report was non-serious.